DR. AMY SUZON CHAPPELL, M.D.
Neurology at Bayberry Ct, Indianapolis, IN
License number
Indiana 01030717
Category
Neurology
Type
Neurology with Special Qualifications in Child Neurology
Address
Address
8111 Bayberry Ct, Indianapolis, IN 46250
Phone
(317) 595-3002
(317) 277-6286 (Fax)
(317) 277-6286 (Fax)
Professional information
Senior Medical Director
Position:
Senior Medical Director at Eli Lilly and Company
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
Eli Lilly and Company
since Jun 1988
-
Senior Medical Director
Texas Christian University
- Fort Worth, TX 2008 - 2010
-
Parent of student
Antioch University
1999 - 2009
-
BOT
Youth Sport Fitness and Health Clinic
1985 - 1988
-
Director
Education:
The Johns Hopkins University School of Medicine 1979 - 1980
The Johns Hopkins University School of Medicine 1977 - 1979
Indiana University School of Medicine 1973 - 1977
MD, Medicine Antioch College 1971 - 1973
BS, Biology The George Washington University 1969 - 1971
The Johns Hopkins University School of Medicine 1977 - 1979
Indiana University School of Medicine 1973 - 1977
MD, Medicine Antioch College 1971 - 1973
BS, Biology The George Washington University 1969 - 1971
Skills:
Neuroscience, Neurology, Alzheimer's disease, Pain Management, Drug Development, Clinical Research, Clinical Trials, Lifesciences, Biotechnology, Pharmaceutical Industry, Clinical Development, Translational Medicine, Clinical Pharmacology
Dr. Amy S Chappell, Indianapolis IN - MD (Doctor of Medicine)
Specialties:
Pediatric Neurology
Address:
Amy S Chappell MD
893 S Delaware St, Indianapolis 46225
(317) 277-3846 (Phone)
893 S Delaware St, Indianapolis 46225
(317) 277-3846 (Phone)
Certifications:
Neurology with Special Qualification in Child Neurology, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Indiana University / School of Medicine
Graduated: 1977
Indiana University School Of Medicine
The Johns Hopkins Hospital
Indiana University / School of Medicine
Graduated: 1977
Indiana University School Of Medicine
The Johns Hopkins Hospital
Amy Suzon Chappell, Indianapolis IN
Specialties:
Neurology, Neurology with Special Qualifications in Child Neurology
Work:
Lily Corporate Center
893 S Delaware St, Indianapolis, IN 46225
893 S Delaware St, Indianapolis, IN 46225
Education:
Indiana University(1977)
Use Of Sulfonamide Derivatives As Pharmaceuticals Compounds
US Patent:
2004023, Nov 25, 2004
Filed:
Mar 26, 2004
Appl. No.:
10/491030
Inventors:
David Bleakman - Zionsville IN, US
Amy Chappell - Indianapolis IN, US
Amy Chappell - Indianapolis IN, US
International Classification:
A61K031/18
US Classification:
514/602000, 514/603000
Abstract:
The present invention provides a method of treating Bipolar I Disorder, Single Manic Episode; Bipolar I Disorder, Most Recent Episode Hypomanic; Bipolar I Disorder, Most Recent Episode Manic; Bipolar I Disorder, Most Recent Episode Mixed; Bipolar I Disorder, Most Recent Episode Depressed; Bipolar I Disorder, Most Recent Episode Unspecified; Bipolar II Disorder; or Bipolar Disorder NOS, in a patient, comprising administering to said patient an effective amount of a compound selected from the group consisting of: A) 2-[4-(4-{2-[(methylsulfonyl)amino]ethyl}phenyl)phenyl]propyl}[(methylethyl)sulfonyl]amine; B) {(2R)-2-[4-(4-{2-[(methylsulfonyl)amino]ethyl}phenyl)phenyl]propyl}[(methylethyl)sulfonyl]amine; D) N-2-(4-N-(3,5-Difluorobenzamido)phenyl)propyl-2-propanesulfonamide; and E) N-[4-((1R)-1-methyl-2-{[(methylethyl)sulfonyl]amino}ethyl)phenyl](3,5-difluorophenyl)carboxamide; and the pharmaceutically acceptable salts thereof.